Literature DB >> 7905003

Endocytosis occurs independently of annexin VI in human A431 cells.

E Smythe1, P D Smith, S M Jacob, J Theobald, S E Moss.   

Abstract

Annexin VI is one of a family of calcium-dependent phospholipid-binding proteins. Although the function of this protein is not known, various physiological roles have been proposed, including a role in the budding of clathrin-coated pits (Lin et al., 1992. Cell. 70:283-291.). In this study we have investigated a possible endocytotic role for annexin VI in intact cells, using the human squamous carcinoma cell line A431, and report that these cells do not express endogenous annexin VI, as judged by Western and Northern blotting and PCR/Southern blotting. To examine whether endocytosis might in some way be either facilitated or inhibited by the presence of annexin VI, a series of A431 clones were isolated in which annexin VI expression was achieved by stable transfection. These cells expressed annexin VI at similar levels to other human cell types. Using assays for endocytosis and recycling of the transferrin receptor, we report that each of these cellular processes occurs with identical kinetics in both transfected and wild-type A431 cells. In addition, purified annexin VI failed to support the scission of coated pits in permeabilized A431 cells. We conclude that annexin VI is not an essential component of the endocytic pathway, and that in A431 cells, annexin VI fails to exert any influence on internalization and recycling of the transferrin receptor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7905003      PMCID: PMC2119942          DOI: 10.1083/jcb.124.3.301

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  36 in total

1.  Alternative splicing gives rise to two forms of the p68 Ca2(+)-binding protein.

Authors:  S E Moss; M J Crumpton
Journal:  FEBS Lett       Date:  1990-02-26       Impact factor: 4.124

2.  Modulation of Ca2+ release channel activity from sarcoplasmic reticulum by annexin VI (67-kDa calcimedin).

Authors:  M Díaz-Muñoz; S L Hamilton; M A Kaetzel; P Hazarika; J R Dedman
Journal:  J Biol Chem       Date:  1990-09-15       Impact factor: 5.157

3.  Fusion between vesicles from the pathway of receptor-mediated endocytosis in a cell-free system.

Authors:  P G Woodman; G Warren
Journal:  Eur J Biochem       Date:  1988-04-05

Review 4.  Diversity in the lipocortin/calpactin family.

Authors:  M R Crompton; S E Moss; M J Crumpton
Journal:  Cell       Date:  1988-10-07       Impact factor: 41.582

5.  Identity of inositol 1,2-cyclic phosphate 2-phosphohydrolase with lipocortin III.

Authors:  T S Ross; J F Tait; P W Majerus
Journal:  Science       Date:  1990-05-04       Impact factor: 47.728

6.  Molecular cloning of murine p68, a Ca2+-binding protein of the lipocortin family.

Authors:  S E Moss; M R Crompton; M J Crumpton
Journal:  Eur J Biochem       Date:  1988-10-15

7.  The crystal and molecular structure of human annexin V, an anticoagulant protein that binds to calcium and membranes.

Authors:  R Huber; J Römisch; E P Paques
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

8.  Primary structure of the human, membrane-associated Ca2+-binding protein p68 a novel member of a protein family.

Authors:  M R Crompton; R J Owens; N F Totty; S E Moss; M D Waterfield; M J Crumpton
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

9.  Formation of coated vesicles from coated pits in broken A431 cells.

Authors:  E Smythe; M Pypaert; J Lucocq; G Warren
Journal:  J Cell Biol       Date:  1989-03       Impact factor: 10.539

10.  ATP is required for receptor-mediated endocytosis in intact cells.

Authors:  S L Schmid; L L Carter
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

View more
  20 in total

1.  Functional analysis of the human annexin I and VI gene promoters.

Authors:  S R Donnelly; S E Moss
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

2.  The association of annexin I with early endosomes is regulated by Ca2+ and requires an intact N-terminal domain.

Authors:  J Seemann; K Weber; M Osborn; R G Parton; V Gerke
Journal:  Mol Biol Cell       Date:  1996-09       Impact factor: 4.138

Review 3.  Annexin A6-A multifunctional scaffold in cell motility.

Authors:  Thomas Grewal; Monira Hoque; James R W Conway; Meritxell Reverter; Mohamed Wahba; Syed S Beevi; Paul Timpson; Carlos Enrich; Carles Rentero
Journal:  Cell Adh Migr       Date:  2017-01-06       Impact factor: 3.405

4.  Human annexin A6 interacts with influenza a virus protein M2 and negatively modulates infection.

Authors:  Huailiang Ma; François Kien; Maxime Manière; Yang Zhang; Nadège Lagarde; Kong San Tse; Leo Lit Man Poon; Béatrice Nal
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

Review 5.  Functional and genetic analysis of annexin VI.

Authors:  H C Edwards; S E Moss
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

6.  Immunological development and cardiovascular function are normal in annexin VI null mutant mice.

Authors:  T E Hawkins; J Roes; D Rees; J Monkhouse; S E Moss
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

7.  Functional implications of nitric oxide produced by mitochondria in mitochondrial metabolism.

Authors:  C Giulivi
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

8.  Molecular cloning of a novel N-terminal variant of annexin II from rat basophilic leukaemia cells.

Authors:  A L Upton; S E Moss
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

9.  Identification and partial sequence analysis of novel annexins in Lytechinus pictus oocytes.

Authors:  W J Shen; J Avery; N F Totty; J J Hsuan; M Whitaker; S E Moss
Journal:  Biochem J       Date:  1994-12-15       Impact factor: 3.857

10.  Structure of the human annexin VI gene.

Authors:  P D Smith; A Davies; M J Crumpton; S E Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.